Elevated GH and insulin-like growth factor 1 (IGF-1) levels are known to stimulate cellular proliferation through mitogenic signaling pathways and have been implicated in increased overall tumor risk, although a direct causal link with schwannoma development has not been established [6,7]. This evidence concerns the gene GH1 and schwannoma.